Stay updated on Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- ChecktodayChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor backend/documentation update to the study record.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a software/version update to the site rather than a change to study content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2, indicating an updated page build. This reflects an internal update or bug fix rather than substantive changes to the study information.SummaryDifference0.0%

- Check44 days agoChange DetectedA new revision label (v3.6.2) has been added, replacing the previous v3.6.0. This reflects a minor maintenance update to the page or its underlying documentation rather than a change to study details or user-facing features.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now indicates that it is no longer recruiting participants. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header, accompanied by a revision tag (Revision: v3.6.0).SummaryDifference0.4%

- Check65 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a new platform build. This change does not affect study details or other visible content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.